Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial.
about
Interventions to improve the appropriate use of polypharmacy for older peopleInterventions to improve the appropriate use of polypharmacy for older peopleAssociation between smoking, crack cocaine abuse and the discontinuation of combination antiretroviral therapy in Recife, Pernambuco, BrazilAdherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104Long-term patient adherence to antiretroviral therapy.A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men.Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia.High risk of ART non-adherence and delay of ART initiation among HIV positive double orphans in Kigali, Rwanda.Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug usersYoung age predicts poor antiretroviral adherence and viral load suppression among injection drug users.Clinical trial simulation: a tool for understanding study failures and preventing them.A proposal for quality standards for measuring medication adherence in researchModeling and simulation of adherence: approaches and applications in therapeutics.Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoringAdherence of antidepressants during pregnancy: MEMS compared with three other methods.Adherence among rural HIV-infected patients in the deep south: a comparison between single-tablet and multi-tablet once-daily regimens.The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states.Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs.A DYNAMIC BAYESIAN NONLINEAR MIXED-EFFECTS MODEL OF HIV RESPONSE INCORPORATING MEDICATION ADHERENCE, DRUG RESISTANCE AND COVARIATES().Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients.Self-reported nonadherence with antiretroviral drugs predicts persistent condition.Barriers to use of electronic adherence monitoring in an HIV clinic.Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.Placebo practice trials: a tool to assess and improve adherence readiness.Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes.A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure.Nonadherence to HIV Treatment: Implications for Health Educators
P2860
Q24193171-724D5B3B-9BB7-41F1-A614-996555BD4C8AQ24197711-15235B5E-FE46-4966-9782-256A89069A66Q33859665-33EED75C-7638-4D40-A235-40616A3BDC2AQ33897610-AA5D8A4B-45B6-446E-A16E-18EA990BAF5AQ33946511-63DAD83A-F9D9-4C48-8EE7-71918A34C7FFQ33971441-155F1F95-574D-49A2-AE66-F6327391DDBDQ34335232-7AFD11D0-57F4-474F-AD66-F34D7290FBD2Q34364382-9AA0261E-6468-4672-9BB4-F0E56D31C119Q34743004-47022FEC-AFC9-4033-9D7A-F518FCB9D255Q36005097-FE64280D-DAE8-4074-A444-A3398BBF40DFQ36055589-2D8D5E55-DE90-41A9-9288-4801C856E496Q36210156-A31B3928-73BF-4020-B8C8-10CD53ADA55AQ36341606-64B5B128-507E-4029-B6FF-52D20F4320FDQ36374300-6CB03F2F-8412-48F1-BF48-C9CBBAB00F02Q37217490-BF966D37-FE18-4DAF-B5E2-9C352394733EQ37634873-E0B46B0A-9890-4B3D-93EC-8930E1753390Q38261526-D54E1DC4-D259-4567-8900-570FD83ACB7DQ38473145-A27DB253-2604-4AD0-8361-3106514D2EA8Q39064765-6023D5E9-E485-4500-BFE6-B554A40D9BB7Q40682598-14C43ABA-2B66-4DB6-90E7-F6193044A06FQ40684898-55C109BC-0631-4DD4-9FE8-7DC67A7C405DQ41153820-6D881399-6420-4DF4-AA0C-9A7BB214770DQ43260037-A5E7FD6E-E393-47F0-A4B4-D653677A0FA7Q43759309-F7F40619-CC4D-42D3-A18B-A258A7453533Q44768959-1EEC5D3F-F46E-4297-AF72-CC0209ADE9D1Q45710950-7EFB3A22-2152-4270-90C1-A76052E71BB7Q46168619-C2450062-94FC-4411-AE3D-7C25A51B232DQ51961912-5FC905E2-E6C9-443E-96E0-ECEAD0D98512Q52025965-14186C9E-EFDE-48E5-B1E5-604AB5BA78C2Q58283543-F321957D-B39D-49DF-9275-04EE950C0FA2
P2860
Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Characterizing patterns of dru ...... men in an AIDS clinical trial.
@en
Characterizing patterns of dru ...... men in an AIDS clinical trial.
@nl
type
label
Characterizing patterns of dru ...... men in an AIDS clinical trial.
@en
Characterizing patterns of dru ...... men in an AIDS clinical trial.
@nl
prefLabel
Characterizing patterns of dru ...... men in an AIDS clinical trial.
@en
Characterizing patterns of dru ...... men in an AIDS clinical trial.
@nl
P2093
P1433
P1476
Characterizing patterns of dru ...... men in an AIDS clinical trial.
@en
P2093
Blaschke TF
Kastrissios H
Katzenstein D
Sheiner LB
P304
P356
10.1097/00002030-199817000-00011
P407
P577
1998-12-01T00:00:00Z